US Patent Issued to UNIVERSITY HEALTH NETWORK on Jan. 27 for "Treatment for acute myeloid leukemia or myelodysplastic syndrome" (Canadian Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,357, issued on Jan. 27, was assigned to UNIVERSITY HEALTH NETWORK (Toronto).

"Treatment for acute myeloid leukemia or myelodysplastic syndrome" was invented by Mark R. Bray (Oakville, Canada), Jacqueline M. Mason (Toronto) and Graham Fletcher (Toronto).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is related to a method of treating a subject with acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, non-Hodgkin's lymphoma, Burkitt lymphoma, or diffuse large B-cell lymphoma, or myelodysplastic syndrome by administration of Compound (I): (I), or a pharmaceutically acceptable salt thereof."

The patent was filed ...